Bellerophon Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Bellerophon Therapeutics, Inc. reported Earnings Per Share, Basic and Diluted of -$0.44 per share for the 3-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2018-03-15
- Bellerophon Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2017-12-31 was -$0.44.
- Bellerophon Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2017-09-30 was -$0.22.
- Bellerophon Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2017-06-30 was -$0.12.
- Bellerophon Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2017-03-31 was -$0.60.
- Bellerophon Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2017 was -$1.41.
- Bellerophon Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2016 was -$1.58.
- Bellerophon Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2015 was -$3.79.
- Bellerophon Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2014 was -$7.56.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$0.44 10-K · filed 2018-03-15 | -$1.41 10-K · filed 2018-03-15 | ||
| 2017-09-30 | -$0.22 10-K · filed 2018-03-15 | -$0.92 10-Q · filed 2017-11-07 | ||
| 2017-06-30 | -$0.12 10-K · filed 2018-03-15 | -$0.70 10-Q · filed 2017-08-07 | ||
| 2017-03-31 | -$0.60 10-K · filed 2018-03-15 | |||
| 2016-12-31 | -$0.37 10-K · filed 2018-03-15 | -$0.68 derived: net income ÷ weighted average shares · filed 2018-03-15 | -$1.07 derived: net income ÷ weighted average shares · filed 2018-03-15 | -$1.58 10-K · filed 2018-03-15 |
| 2016-09-30 | -$0.30 10-K · filed 2018-03-15 | -$0.69 derived: net income ÷ weighted average shares · filed 2018-03-15 | -$1.23 10-Q · filed 2017-11-07 | -$2.05 derived: net income ÷ weighted average shares · filed 2018-03-15 |
| 2016-06-30 | -$0.39 10-K · filed 2018-03-15 | -$0.93 10-Q · filed 2017-08-07 | -$1.76 derived: net income ÷ weighted average shares · filed 2018-03-15 | -$2.62 derived: net income ÷ weighted average shares · filed 2018-03-15 |
| 2016-03-31 | -$0.54 10-K · filed 2018-03-15 | -$1.37 derived: net income ÷ weighted average shares · filed 2018-03-15 | -$2.23 derived: net income ÷ weighted average shares · filed 2018-03-15 | -$3.13 derived: net income ÷ weighted average shares · filed 2018-03-15 |
| 2015-12-31 | -$0.83 10-K · filed 2017-03-13 | -$1.69 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$2.59 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$3.79 10-K · filed 2018-03-15 |
| 2015-09-30 | -$0.86 10-K · filed 2017-03-13 | -$1.76 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$2.97 10-Q · filed 2016-11-08 | -$4.41 derived: net income ÷ weighted average shares · filed 2017-03-13 |
| 2015-06-30 | -$0.90 10-K · filed 2017-03-13 | -$2.12 10-Q · filed 2016-08-09 | -$3.61 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$5.43 derived: net income ÷ weighted average shares · filed 2017-03-13 |
| 2015-03-31 | -$1.27 10-K · filed 2017-03-13 | -$2.84 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$4.76 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$6.86 derived: net income ÷ weighted average shares · filed 2017-03-13 |
| 2014-12-31 | -$1.62 10-K · filed 2016-03-21 | -$3.58 derived: net income ÷ weighted average shares · filed 2016-03-21 | -$5.72 derived: net income ÷ weighted average shares · filed 2016-03-21 | -$7.56 10-K · filed 2017-03-13 |
| 2014-09-30 | -$1.96 10-K · filed 2016-03-21 | -$4.10 derived: net income ÷ weighted average shares · filed 2016-03-21 | -$5.94 10-Q · filed 2015-11-12 | |
| 2014-06-30 | -$2.14 10-K · filed 2016-03-21 | -$3.98 10-Q · filed 2015-08-14 | ||
| 2014-03-31 | -$1.84 10-K · filed 2016-03-21 |